While sIL6R levels have been previously reported to decrease in AD cases [84], a recent study using a much larger sample found a significant increase in CSF sIL6R levels and increasing ptau181/Aβ42 ratio [50], suggesting a possible relationship between sIL6R levels and AD pathogenesis. Here, IL6R is linked to Alzheimer disease.